A painful bone condition that affects nearly 20,000 Americans each year and that lies at the root of a rare childhood disease ...
The FDA has approved Zycubo (copper histidinate) injection as the first and only treatment of Menkes disease in pediatric ...
MedPage Today on MSN
Rare childhood disorder gets its first FDA drug approval
The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency ...
Focused on therapies for endocrine and oncologic conditions, this biotech reported significant insider selling in its latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback